Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 6 days ( -49.57 % )
Last Price $17.44 43.07 %
High/ Low $16.58 - $18.75 43.67%
Chg 7 Days 49.57 % $11.66 $17.44
Chg 30 Days 42.48 % $12.24 $17.44
Chg 12 mos 23.95 % $14.07 $17.44
Trend - 3 mos 13.27 % Width: 34.29 %
Trend - 12 mos -19.24 % Width: 124.38 %
Pred. range - 3 mos $12.20 - $16.38 -30.07 % - -6.09 %
Pred. range - 12 mos $5.29 - $11.87 -69.66 % - -31.92 %
Short MA avg 3 mos Sell Apr 29, 2024 - 10 days
Long MA avg 3 mos Buy Apr 30, 2024 - 9 days
Short/Long MA avg 3 mos Buy May 07, 2024 - 4 days
Short MA avg 12 mos Buy Apr 30, 2024 - 9 days
Long MA avg 12 mos Buy Apr 30, 2024 - 9 days
Short/Long MA avg 12 mos Buy Jan 04, 2024 - 89 days
Pivot Short Buy Apr 18, 2024 - 17 days
Bollinger Buy Mar 27, 2024 - 32 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Iteos Therapeutics Inc.

Iteos Therapeutics. Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used t... ITOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT